Literature DB >> 2476266

Circadian variation of GH-independent IGF-binding protein in diabetes mellitus and its relationship to insulin. A new role for insulin?

J M Holly1, R A Biddlecombe, D B Dunger, J A Edge, S A Amiel, R Howell, T Chard, L H Rees, J A Wass.   

Abstract

Evidence is accumulating that a non-GH dependent insulin-like growth factor-binding protein (IGF-BP) is not only a carrier protein but also has an active role in the growth process. We have measured levels of this IGF-BP, using a specific RIA, over 12 or 24-h periods in 11 adolescents with diabetes mellitus and five normal adults. In each of the normal the IGF-BP was undetectable for most of the day but with a broad nocturnal peak observed, with levels up to 50 micrograms/l. The levels of IGF-BP were unrelated to the secretory pattern for GH but correlated inversely with the concentration of circulating insulin. In the diabetics a very similar pattern was observed, but with detectable levels throughout the day and much higher peak levels seen at night. Peak levels were up to 120 micrograms/l if a long-acting insulin preparation was administered in the evening but were 400-500 micrograms/l if the long-acting preparation was administered in the morning. The IGF-BP was strongly correlated with plasma glucose in this latter group. In a further group of diabetics overnight profiles were obtained on two separate nights, a normal night and a night with euglycaemia maintained with a glucose clamp technique. Euglycaemia failed to affect peak levels of the binding protein, although the shape of the nocturnal peak was altered consistent with the altered pattern of circulating free insulin. In this group a strong inverse correlation was obtained between the IGF-BP and free insulin levels.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2476266     DOI: 10.1111/j.1365-2265.1988.tb03715.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  20 in total

Review 1.  The insulin-like growth factor family of ligands, receptors, and binding proteins.

Authors:  R F Krywicki; D Yee
Journal:  Breast Cancer Res Treat       Date:  1992       Impact factor: 4.872

2.  Proliferative retinopathy with growth hormone deficiency and diabetes mellitus.

Authors:  J D Quin; A C MacCuish; D Gordon
Journal:  BMJ       Date:  1990-06-16

3.  Maternal insulin-like growth factor binding protein-1, body mass index, and fetal growth.

Authors:  R P Holmes; J M Holly; P W Soothill
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2000-03       Impact factor: 5.747

Review 4.  Somatomedin-binding proteins: what role do they play in the growth process?

Authors:  S Cianfarani; J M Holly
Journal:  Eur J Pediatr       Date:  1989-11       Impact factor: 3.183

5.  Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patients.

Authors:  V Gasco; G Beccuti; F Marotta; N Prencipe; M Maccario; J Janssen; A J van der Lely; E Ghigo; S Grottoli
Journal:  J Endocrinol Invest       Date:  2011-05-31       Impact factor: 4.256

6.  Circulating insulin-like growth factors and IGF-binding proteins in PSA-detected prostate cancer: the large case-control study ProtecT.

Authors:  Mari-Anne Rowlands; Jeff M P Holly; David Gunnell; Jenny Donovan; J Athene Lane; Freddie Hamdy; David E Neal; Steven Oliver; George Davey Smith; Richard M Martin
Journal:  Cancer Res       Date:  2011-11-21       Impact factor: 12.701

Review 7.  Insulin and insulin-like growth factors in diabetes mellitus.

Authors:  D B Dunger
Journal:  Arch Dis Child       Date:  1995-06       Impact factor: 3.791

Review 8.  Nutrition, hormones, and breast cancer: is insulin the missing link?

Authors:  R Kaaks
Journal:  Cancer Causes Control       Date:  1996-11       Impact factor: 2.506

9.  RTEF-1 attenuates blood glucose levels by regulating insulin-like growth factor binding protein-1 in the endothelium.

Authors:  Angela F Messmer-Blust; Melissa J Philbrick; Shuzhen Guo; Jiaping Wu; Ping He; Shaodong Guo; Jian Li
Journal:  Circ Res       Date:  2012-07-25       Impact factor: 17.367

10.  Elevated plasma insulin-like growth factor binding protein-1 levels in type 1 (insulin-dependent) diabetic patients with peripheral neuropathy.

Authors:  S R Crosby; C Tsigos; C D Anderton; C Gordon; R J Young; A White
Journal:  Diabetologia       Date:  1992-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.